Skip to main content
Premium Trial:

Request an Annual Quote

Certara, LabLogic Sign Software Integration Agreement

Premium

Certara and LabLogic Systems have signed an agreement to integrate software products in their portfolios.

Under the contract terms, Certara’s Phoenix WinNonlin pharmacokinetic/pharmacodynamic modeling and non-compartmental analysis product will be integrated with LabLogic’s Debra Laboratory Information Management System (LIMS) solution, which is used to manage data from absorption, distribution, metabolism, and excretion and protein-binding studies.

Huw Loaring, systems director at LabLogic, said in a statement, that the companies decided to integrate their products “in direct response to customer requests. We are always looking for ways to help our pharmaceutical customers to streamline their drug discovery process.”

The combined solution, Certara said, allows customers using Debra LIMS push their data directly into Phoenix WinNonlin. This direct communication “will increase system usability and should also provide quality control benefits,” Daniel Weiner, Certara’s senior vice president and general manager, said in a statement.

LabLogic is managing customer requests for this product integration.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.